(Received for publication, September 16, 1996, and in revised form, January 16, 1997)
From the Department of Anatomy and Cell Biology, Health Science Center, University of Florida, Gainesville, Florida 32610
We have generated monoclonal antibodies against nuclear proteins from the yeast Saccharomyces cerevisiae. The monoclonal antibodies react with proteins of 47 and 49 kDa on immunoblots and with partially overlapping sets of proteins on two-dimensional nonequilibrium pH gradient electrophoresis-SDS blots. Immunofluorescence localization shows a nuclear staining pattern. Immunoscreening a yeast expression library yielded five independent full-length clones of two open reading frames from chromosome IV, corresponding to YDL182w (LYS20) and YDL131w in the Saccharomyces genome data base. These two open reading frames are predicted to encode homocitrate synthase isozymes of 47 and 49 kDa, respectively. A clone carrying YDL182w was sequenced in its entirety and directs the expression of a 47-kDa protein in Escherichia coli. A clone carrying YDL131w expresses a 49-kDa protein in E. coli. Yeast grown in minimal medium plus lysine show significant reductions in nuclear immunofluorescence staining. Cell fractionation studies localize the 47- and 49-kDa proteins to the nucleus. Nuclear fractionation studies reveal that a portion of the 47- and 49-kDa proteins can only be extracted with DNase digestion and high salt. The localization of homocitrate synthase to the nucleus is unexpected given previous reports that homocitrate synthase is present in mitochondria and the cytoplasm in S. cerevisiae.
In yeast, higher fungi, and euglenids, lysine is synthesized via
the -aminoadipate pathway, which is only found in these organisms
(1). Homocitrate synthase catalyzes the first committed reaction in
this pathway and is thought to be an important site of control of
metabolic flow. In Saccharomyces cerevisiae, two isozymes
have been identified by isoelectric focusing of purified enzyme
preparations (2). Both isozymes are feedback inhibited by lysine, but
only one is transcriptionally repressed by lysine (2).
Genes for the homocitrate synthase isozymes have not been identified until recently, despite extensive genetic analyses of lysine auxotrophs, which have revealed most of the enzyme-encoding (LYS) genes required in this pathway. During the sequencing of chromosome IV of S. cerevisiae, an open reading frame (ORF)1 was identified that encoded a protein with significant homology to homocitrate synthase from other yeasts (3). This ORF is designated YDL182w in the Saccharomyces genome data base (GenBankTM accession number X83276[GenBank], ORF D1298). Ramos et al. (4) have disrupted this gene, examined the effects on lysine production and levels of homocitrate synthase enzymatic activity, and named this gene LYS20.
The subcellular localization of enzymes of the -aminoadipate pathway
has been investigated in S. cerevisiae, and the enzymes for
the first half of the pathway have been reported to be located in the
mitochondrion (reviewed in Ref. 5). Two reports place homocitrate
synthase from S. cerevisiae in mitochondria (6, 7).
Jaklitsch and Kubicek (8) reported that homocitrate synthase from
Penicillium chrysogenum is present in the mitochondrion and
cytosol.
We have generated four monoclonal antibodies against homocitrate
synthase isozymes and present evidence that the majority of homocitrate
synthase is localized to the nucleus in S. cerevisiae. As
discussed below, this unexpected finding may be reconciled with
previous results by consideration of the cell fractionation techniques
used in previous studies. Thus, our findings extend previous cell
fractionation studies and do not necessarily contradict them. The
localization of homocitrate synthase to the nuclear compartment is
likely to provide new insights into the -aminoadipate pathway for
lysine biosynthesis, and more generally, into aspects of nuclear
function in S. cerevisiae.
mAb 31F5 was generated during the
preparation of monoclonal antibodies to a nucleolus-enriched fraction
derived from yeast nuclei.2 Balb/c mice
were immunized with nucleoli suspended in RIBI adjuvant (Immunochem
Research, Inc., Hamilton, MT), boosted on a regular schedule, and bled
for analysis of the immune response by Western blotting and
immunofluorescence. Spleen cells were harvested from the mouse with the
most robust and complex immune response, and fused with NS myeloma
cells, and plated in four media: (i) HCM (hybridoma complete medium,
Ref. 10) + 10% conditioned HCM; (ii) HCM + 10% conditioned HCM + origin supplement (Igen Inc., Gaithersburg, MD); (iii) HCM + 10%
conditioned HCM + spleenocyte feeder; (iv) HCM + 10% conditioned HCM + spleenocyte feeder + origin supplement. Hybridomas in each medium were
plated in 10, 96-well dishes to attain an average one colony per well.
The yields of colonies from each medium were as follows: 17 colonies in
medium i; 297 colonies in medium ii; 136 in medium iii; and 287 in
medium iv. Wells were scored for the presence of one or more colonies at more than one time after fusion. Priority was given to single colonies. Supernatants (737) from 96-well plates were screened by
immunofluorescence using a hexaploid yeast strain (Yeast Genetic Stock
Center) and multiwell slides that were prepared in advance and stored
dry at 4 °C until use. Clones (199) giving a nucleolar or nuclear
staining pattern were expanded to 48-well plates, from which
supernatants were screened by Western blotting. Of 199 supernatants that produced a nuclear staining pattern, 8 reacted with proteins of
45-50 kDa on Western blots. One of these, 31F5, was selected for
further study. mAbs C65, D61, and D62 were generated in a screen for
antinuclear antibodies that was described previously (11). mAb B47
recognizes Nsr1p, the nucleolar protein encoded by NSR1
(12), based on results from screening a gt11
library.3 All of the mAbs are IgG, isotype
1-
. Cell fusion, hybridoma culture, and ascites fluid production
were done using standard methods by the Hybridoma Laboratory of the
Interdisciplinary Center for Biotechnology Research at the University
of Florida.
SDS-PAGE in one dimension in 10.5% gels, transfer to nitrocellulose membrane, and incubations with antibodies were done as described previously (13, 14). For two-dimensional gels, separation in the first dimension was done using nonequilibrium pH gradient electrophoresis (NEPHGE), followed by SDS-PAGE on 10.5% gels in the second dimension, as described previously (11). The resolution of nuclear proteins (100 µg of total protein) was improved by digesting nucleic acids with 2 units of micrococcal nuclease for 10 min at 25 °C prior to NEPHGE.
Immunofluorescence LocalizationThe protease-deficient haploid BJ2168 (15) and a W303 diploid were grown at 30 °C in YPD medium (1% yeast extract, 2% peptone, 2% dextrose) and were used for indirect immunofluorescence localization as described (13). Growth in synthetic dextrose or synthetic glycerol-lactate medium (synthetic base plus 1% glycerol and 1% lactate), with or without 100 µg/ml L-lysine was done at 30 °C (16). Ascites fluids or mAb supernatants of 31F5, or C65, D61, and D62, were used at dilutions of 1/250 or 1/5, respectively. Secondary antibody anti-mouse-Cy3 conjugate (Jackson ImmunoResearch Laboratories) was diluted 1/200.
Library Immunoscreening, PCR Analysis, and DNA SequencingA yeast genomic expression library in gt11
(Clontech) was screened using standard techniques (17), using mAb 31F5
ascites fluid at a dilution of 1/1000. Positive plaques were purified, and the insert DNA analyzed by direct PCR amplification of
phage suspensions using primers flanking the EcoRI site. Of 25 positives analyzed by PCR, 8 had unique sized inserts. Five positives
(#9, #15, #20, #25, and #39) were selected for further analysis on the
basis of efficient amplification of a single PCR product band. DNA
sequence from both ends of each of the six PCR products was obtained
through the DNA Sequencing Laboratory of the Interdisciplinary Center
for Biotechnology Research at the University of Florida.
DNA was
purified from #9 and the 2.6-kilobase pair insert was excised with
EcoRI and cloned into pBluescript II KS+ to give plasmid
pJPA50. The 2.6-kilobase pair PCR product from #20 was ligated into the
TA site of the pT7-Blue vector to give plasmid pJPA72. E. coli DH5
was used for transformations and plasmid preparations
(17). Amino acid alignments were generated using the method of Lipman
and Pearson (18), as implemented by MacDNAsis software.
The E. coli strain
Y1089 was lysogenized with isolates #9 or #20, and induction of
protein expression was accomplished with 1 mM IPTG in LB
medium as described (19). For SDS-PAGE, bacteria were treated with 10%
trichloroacetic acid, centrifuged, washed with 1% trichloroacetic
acid, and lysed in the presence of 10% trichloroacetic acid with glass
beads. After centrifugation, the pellet was boiled for 5 min in
SDS-PAGE sample buffer containing EDTA and a protease inhibitor
mixture2 and centrifuged prior to electrophoresis.
The S. cerevisiae strain BJ2168 was used for preparation of nuclei according to Ref. 20. Cell fractions were obtained from different layers of a Ficoll 400 step gradient that is used in the final step of isolation of yeast nuclei and are virtually identical to those described in Ref. 13. Nuclear subfractionation was done according to Ref. 13.
During the preparation of monoclonal antibodies against
nucleus- and nucleolus-enriched fractions from yeast, we identified four monoclonals that reacted with proteins of apparent molecular masses 47 and 49 kDa (Fig. 1). mAbs C65, D61, and D62
resulted from a screen for nuclear-specific monoclonal antibodies,
whereas monoclonal 31F5 resulted from a screen for nucleolar-specific monoclonals (see "Experimental Procedures").
Isolated yeast nuclei are characterized by prominent SDS-PAGE bands corresponding to histones and the nucleolar protein Nop1p, whereas in nucleolar preparations, Nop1p is further enriched, but histones are depleted (Fig. 1). mAb 31F5 recognizes the 47- and 49-kDa proteins present in yeast nuclei and nucleoli prepared from isolated nuclei (Fig. 1). The band at 47 kDa appears to consist of a doublet of closely migrating bands. D61 recognizes the 47-kDa band, but the 49-kDa band only weakly. C65 reacts with the 47-kDa band, but does not recognize a 49-kDa band (Fig. 1), even after long exposures of the Western blot (not shown). Like mAb 31F5, D62 recognizes two pairs of closely migrating protein bands that have apparent molecular masses of 47 and 49 kDa (Fig. 1).
The immunologic reactivities of mAbs 31F5 and D62 suggest the recognition of shared epitopes on related proteins. Results with C65 suggest monospecific immunoreactivity. The pattern of immunologic reactivity of mAb D61 appears distinct from the other three insofar as the epitope is recognized avidly in one protein, but to a reduced extent in the other. Also, 31F5 appears similar to D62. Three explanations for these findings are: (i) the existence of distinctly different proteins of similar molecular masses; (ii) the presence of one protein with multiple post-translational modifications, each of which is recognized by a mAb; or (iii) a combination in which two (or more) similar proteins share post-translational modifications.
To compare the reactivities of the mAbs, nuclear proteins were
separated on two-dimensional NEPHGE-SDS gels and probed by immunoblotting. NEPHGE was used in the first dimension instead of
isoelectric focusing, because it gave better separation of immunoreactive proteins (data not shown). Interestingly, mAbs C65, D61,
and D62 react with distinct, but overlapping, sets of proteins on
two-dimensional gels (Fig. 2). D62 reacts with the largest number of proteins (Fig. 2C). C65 and D61 each
reacts with a smaller number of proteins, each of which appears to be recognized by D62 (Fig. 2, A and B). The
detection of multiple proteins suggests the presence of different
isoforms of the same mobility on SDS-PAGE gels.
To assess the similarity of 31F5 and D62, immunoblots from
two-dimensional gels were compared (Fig. 2, E and
F). The patterns of reactivity appear identical, suggesting
that 31F5 and D62 recognize the same epitope. The immunoblotting
results from E. coli lysogens are consistent with this (see
below and Fig. 5). These data suggest that the monoclonals fall into
three classes of immunologic reactivity.
Immunofluorescence Localization
To evaluate the intracellular
distribution of the 47- and 49-kDa proteins, we performed indirect
immunofluorescence localization using procedures described previously
(13). Immunofluorescence signals obtained with the mAbs were compared
with staining with DAPI, which intercalates into DNA and marks the
distribution of chromatin and mitochondrial DNA in the cell. All four
monoclonal antibodies give a primarily, but not exclusively, nuclear
immunofluorescence staining pattern (Fig. 3, A, D,
G, and J). In certain dividing cells, mAb 31F5 reveals
a faint trail of staining between nuclei, which corresponds to a narrow
isthmus-like connection between nuclei in a dividing pair of cells at
the end of mitosis (Fig. 3A, upper right). This faint trail
of staining also stains with DAPI. A faint cytosolic staining is
visible, more in some cells than others, and is most readily seen with
mAb C65 (Fig. 3D). Staining with the secondary antibody
alone is not responsible for this faint cytosolic signal (not shown).
In some cases, the mAb staining patterns appear larger than the DAPI
staining region of the cell. This is due to immunostaining within the
nucleolus, which is not stained with DAPI. Images less bright than
those shown in Fig. 3 reveal a punctate, intranuclear staining pattern throughout the nucleus (not shown). Fig. 3 shows results obtained with
two yeast strains of different genetic backgrounds, a W303 diploid and
a protease deficient strain BJ2168. Considering the intracellular
localization of the 47- and 49-kDa proteins, it is not surprising that
monoclonal antibodies prepared against isolated nuclei and nucleoli
react with these proteins.
Cloning of LYS20 and a Related Gene
To characterize the
immunoreactivity of the monoclonal antibodies at a molecular level, we
elected to screen a yeast expression library with one of the mAbs (see
"Experimental Procedures"). mAb 31F5 was chosen for this because
it, like D62, strongly recognized multiple proteins. Immunoscreening of
a yeast expression library with mAb 31F5 yielded five independent
full-length clones (Fig. 4A). The insert from
one positive clone, #9, was subcloned and sequenced in its entirety
(see "Experimental Procedures," DNA sequence not shown). The 2639 nucleotides of DNA sequence data obtained matched exactly the sequence
on chromosome IV between 132,967 and 135,605 and contained the open
reading frame YDL182w. This sequence has recently been shown to encode
a homocitrate synthase isozyme and has been named LYS20 (4).
Two additional positive clones, #15 and #25, were found to overlap with
#9.
Interestingly, two different positive clones, #20 and #39, carried the open reading frame YDL131w, between 227,393 and 228,715 on chromosome IV (Fig. 4A). To our knowledge, the fact that positive clones #20 and #39 were isolated is the first evidence suggesting that the YDL131w ORF is expressed in yeast. The predicted product from the YDL131w ORF is highly homologous to Lys20p (Fig. 4B). LYS20 is 1287 nucleotides in length, whereas the YDL131w ORF is 1323 nucleotides in length. Lys20p is 428 amino acids, with a predicted molecular weight of 47,096 and the homologue is predicted to have 440 amino acids and a molecular weight of 48,591. The predicted sizes of 47.1 and 48.6 kDa are essentially the same as the apparent molecular masses of 47 and 49 kDa observed on Western blots, although each gene product may not migrate as a single band on SDS gels. Lys20p and its homologue are 90% identical (over 428 positions). The LYS20 gene is approximately 90% identical to YDL131w at the nucleotide level (over 1287 nucleotides). The predicted isoelectric points for Lys20p and its homologue YDL131w are 6.9 and 5.9, respectively. The two previously characterized homocitrate synthase isozymes have isoelectric points of 5.8 and 4.9, the more acidic of which is down-regulated in the presence of lysine (2). Prosite analyses of Lys20p and its homologue revealed the presence of multiple potential phosphorylation sites, but indicated that neither protein contained an amino-terminal mitochondrial presequence or a canonical nuclear localization sequence.
LYS20 and YDL131w Gene Products Expressed in E. coliWe
wished to show that 31F5 recognizes the products of the
LYS20 and YDL131w genes carried on the inserts in clones #9
and #20, respectively, and not -galactosidase fusion proteins. It is
also valuable to demonstrate that these gene products migrate at 47 and
49 kDa as predicted by their primary structure. Also, considering that
immunoscreening a yeast expression library yielded two classes of
positives, and that certain mAbs react with a group of proteins on
Western blots, only a subset of which were recognized by other mAbs, it
is likely that not all of the mAbs recognize the same gene
product. Thus, we wished to further characterize the immunoreactivity
of the other three antibodies.
lysogens were prepared for
heterologous protein expression in E. coli, and Western
blotting was done with mAbs C65, D61, D62, and 31F5 (see
"Experimental Procedures").
A 47-kDa band was detected by mAb 31F5 in an extract from an IPTG-induced E. coli lysogen carrying the insert present in clone #9 (Fig. 5). This band exactly comigrates with the 47-kDa band present in samples of yeast nuclei. The 47-kDa band was not detected in an IPTG-induced extract from a lysogen carrying a clone for the putative acetyl-coenzyme A synthetase 2,4 which was used as a control (Fig. 5). India ink staining of the blot reveals a band of 47 kDa present in samples from lysogen #9, but not from the control (data not shown). This argues that clone #9 was isolated during immunoscreening by virtue of the expression of the 47-kDa protein.
In a similar experiment, a 49-kDa band was detected by mAb 31F5
in extracts from a lysogen carrying clone #20 (Fig. 6).
The 49-kDa band exactly comigrates with the 49-kDa band present in yeast nuclei. The 49-kDa band was not detected in an IPTG-induced extract from E. coli strain Y1089 that was not lysogenized,
which was used as a control (Fig. 6). Several immunoreactive proteins less than 49 kDa are also visible in Fig. 6. Two experiments with independently isolated lysogens of clone #20 yielded the same lower
molecular mass immunoreactive bands. We attribute these bands to
proteolysis of the 49-kDa YDL131w gene product. Proteolysis is not
uncommon in SDS-PAGE lysates of induced lysogens and has apparently
occurred despite precautions taken to reduce proteolysis during sample
preparation (see "Experimental Procedures"). It was not possible to
prepared IPTG-induced protein lysates from clone #39, which also
carries YDL131w. Two independent lysogens of clone #39 spontaneously
lysed during IPTG induction of protein expression in two separate
experiments (data not shown).
The results presented in Figs. 5 and 6 indicate that mAb 31F5 does not
detect a -galactosidase fusion protein, which would be predicted to
have a molecular mass greater than 116 kDa. The 47- and 49-kDa proteins
expressed in E. coli also reacted with monoclonal D62 (Figs.
5 and 6). C65 reacts with the 47-kDa protein expressed in E. coli, but not the 49-kDa protein, which is consistent with the
reactivity of C65 against yeast nuclear proteins (Fig. 1). C65 also
reacted with certain E. coli proteins in control samples,
indicating nonspecific reactivity with the antibody (Fig. 5).
Interestingly, D61 did not react with either Lys20p or the YDL131w gene
product expressed in E. coli (Figs. 5 and 6), even after
long exposures of film (data not shown). The absence of reaction of D61
could be due to the absence of formation of the necessary epitope in
E. coli (e.g. absence of post-translational modification). Like 31F5, mAb D62 reacts with lower molecular mass
bands from clones #9 and #20 (Figs. 5 and 6). The fact that same low
molecular mass bands are recognized by 31F5 and D62 is consistent with
the notion that 31F5 and D62 recognize the same epitope.
The localization of homocitrate synthase to the nucleus contradicts previous studies that suggest cytosolic and/or mitochondrial localization. To generate additional evidence that homocitrate synthase is detected by the mAbs during immunolocalization, we performed the localization with cells grown in the presence or absence of lysine. Additionally, it is possible that the localization of homocitrate synthase is dependent on carbon source and/or presence of lysine. For instance, growth of yeast in YPD, which is routinely used for immunofluorescence localization, does not induce maximal proliferation of mitochondria, and YPD contains lysine, which is known to repress expression of one homocitrate synthase isoform (2). Growth in glycerol-lactate medium in the absence of lysine induces proliferation of mitochondria and expression of homocitrate synthase, which should provide the optimum conditions under which to detect mitochondrial localization.
To test these possibilities, yeast were grown in dextrose or
glycerol-lactate medium, with or without lysine and examined by
immunofluorescence localization. Growth in either carbon source resulted in nuclear localization, with no apparent difference between
them (Fig. 7). The presence of lysine, however,
noticeably reduced the nuclear immunofluorescence staining intensity
(Fig. 7). This reduction is most pronounced for C65, which reacts with Lys20p. The reduction seen with D61 is not as great. Immunofluorescence localization with 31F5 and D62 showed a
lysine-dependent reduction in staining that appeared
identical to that obtained with C65, and neither 31F5 or D62 showed
evidence of cytosolic or mitochondrial staining (data not shown). DAPI
staining of cells shown in Fig. 7 reveals a significant increase in
number of mitochondria in cells grown on the synthetic glycerol-lactate
nonfermentable carbon source (data not shown). The
immunofluorescence intensity observed in Fig. 3, using cells cultured
in YPD, appears intermediate between the intensity in cells grown with
or without lysine in Fig. 7.
Characterization of 47- and 49-kDa Proteins by Cell and Nuclear Fractionation
To address the intracellular localization of the
47- and 49-kDa proteins with an additional technique, subcellular
fractions were analyzed by Western blotting (Fig. 8).
The fractions employed are: purified nuclei (Nu), low
(L) and high (H) density membrane fractions, and
a soluble (S) fraction. These fractions are harvested from a
Ficoll 400 step gradient used to isolate nuclei from a spheroplast
lysate (13). The spheroplast lysate is cleared of unlysed cells and
cell wall debris by a medium speed centrifugation step. The vast
majority of proteins present in the yeast cell are represented in these
four fractions, although cell wall proteins were removed during
spheroplast preparation.
The mAbs C65 and D62 recognize 47- and 49-kDa proteins that are found predominately in the nuclear fraction (Fig. 8). D61 recognizes the 47-kDa isoform most highly enriched in the nuclear fraction (Fig. 8). mAb D61 also recognizes the 49-kDa protein, but only very weakly (as seen in Fig. 1). Some 47- and 49-kDa protein bands are present in the high density membrane fraction, which contains endoplasmic reticulum, plasma membrane, some vacuolar membrane, and a small amount of nuclear fragments and nuclear envelope (20). The non-nuclear reactivity is most readily seen with mAb D62, but the majority of the 47- and 49-kDa proteins are found in the nuclear fraction. To provide a basis for comparison, three other mAbs were used: mAb D77 was used to detect the 38-kDa nucleolar protein Nop1p; mAb B47 was used to detect the 67-kDa nucleolar protein Nsr1p; and the mAb C56 was used to detect the 100-kDa integral plasma membrane protein Pma1p (Fig. 8).
Nuclear fractionation experiments were undertaken to evaluate the
intranuclear localization of the 47- and 49-kDa proteins (Fig.
9). This approach is valuable because certain nuclear
proteins exhibit a typical extraction behavior (13). For example,
histones are extracted from nuclei by DNase I digestion and EDTA
treatment, whereas the nucleolar proteins Nop1p and Nsr1p are not.
Nop1p and Nsr1p are liberated by exposure to high salt. The three
monoclonals, C65, D61, and D62, recognize 47- and 49-kDa proteins, less
than half of which are released by DNase I digestion and EDTA (Fig. 9).
The majority of the 47- and 49-kDa proteins are present in the pellet
fraction (Fig. 9). Of this, the majority is released by exposure of the
pellet to 0.5 M NaCl. Similar behavior is exhibited by the
nucleolar proteins Nop1p and Nsr1p (Fig. 9). This suggests that the
majority of the 47- and 49-kDa proteins present in the nucleus are not
freely diffusible, and a significant portion are tightly bound and can
only be extracted from nuclei with DNase digestion and high salt.
We have generated four monoclonal antibodies specific for
homocitrate synthase in yeast. Homocitrate synthase catalyzes the first
committed step in the -aminoadipate pathway for lysine biosynthesis.
Recently, Ramos et al. (4) have characterized a gene
(YDL182w) encoding an isozyme of homocitrate synthase and have named it
LYS20. These four monoclonal antibodies, C65, D61, D62, and
31F5, recognize Lys20p, which migrates at 47 kDa. The mAbs D62, D61,
and 31F5 also recognize the 49-kDa YDL131w gene product, but D61 does
so only very weakly. The YDL131w gene product is predicted to be
slightly larger than Lys20p and to possess an amino acid sequence 90%
identical to Lys20p.
Our studies using monoclonal antibodies have localized homocitrate synthase to the nucleus. Cell fractionation and immunfluorescence labeling experiments indicate that the majority of homocitrate synthase in yeast is present in the nucleus. The localization of homocitrate synthase to the nucleus is unexpected given the generally accepted view that homocitrate synthase is present in the mitochondrion and cytoplasm in S. cerevisiae (6, 7). One explanation for this discrepancy is that a percentage of homocitrate synthase is not localized in the nucleus and accounts for the previous findings. This is consistent with the results reported herein insofar as we estimate that the majority, but not all, of homocitrate synthase is localized to the nucleus. However, we view it equally likely that previous studies were done in such a manner as to compromise the structural integrity of the nucleus. A widely cited report (6) localizing homocitrate synthase to mitochondria is based on experiments in which mitochondria were isolated by differential centrifugation of a cell-free extract, which yields only a crude preparation. This was done under conditions that we have previously found to be incompatible with isolating intact nuclei from yeast (11, 20). Specifically, Betterton et al. (6) lysed spheroplasts in pH 7.4 buffer, without Mg2+, using sonication. We have found previously that isolation of intact nuclei in good yield requires pH 6.5, at least 1 mM Mg2+, and gentle lysis conditions (11, 20). The "post-nuclear supernatant" obtained by Betterton et al. (6) using differential centrifugation, and the mitochondria obtained from it, are not likely to be free of nuclear fragments and/or constituents. The nuclear fractionation experiments presented herein show that a portion of homocitrate synthase does not freely diffuse out of the nucleus and appears to be associated with a sedimentable nuclear subfraction. This is consistent with the view that a crudely prepared "mitochondria" fraction may contain nuclear fragments. Thus, the observation that homocitrate synthase is present in the nucleus in S. cerevisiae may simply have been overlooked, because the techniques used in previous studies could not adequately differentiate between the mitochondrion and other compartments, such as the nucleus.
Previous studies of homocitrate synthase and lysine biosynthesis have shown that two isoforms of this enzyme are present in S. cerevisiae (2). LYS20 and its homologue YDL131w undoubtedly encode the two isozymes of homocitrate synthase present in yeast. Both the LYS20 gene and its homologue are located on chromosome IV, suggesting that they arose via gene duplication (24). Neither Lys20p, nor the homologous protein, which contains an amino-terminal extension of 14 amino acids, is predicted to have an amino-terminal mitochondrial localization signal. Neither Lys20p, nor its homologue, is predicted to contain a nuclear localization sequence (NLS). This raises the question as to the mechanism by which homocitrate synthase is transported to the nucleus. The 47-kDa size of Lys20p is near the upper limit for diffusion across the nuclear pore complex, but could readily accumulate in the nucleus if bound to a nuclear component (21). Alternatively, nuclear transport of Lys20p may be explained either by "piggyback" transport in association with a nuclear protein, or the presence of an atypical NLS. The nuclear hnRNP A1 protein is a well known example of a protein lacking a typical NLS (22).
Homocitrate synthase catalyzes the first committed step in the
-aminoadipate pathway for lysine biosynthesis. The following four
steps of the pathway, from homocitrate to
-ketoadipate, are thought
to be executed in the mitochondrion, and the next five steps, from
-aminoadipate to lysine, are thought to take place in the cytosol
(1, 5). The localization of homocitrate synthase to the nucleus
implicates the nucleus as an important intracellular compartment for
this pathway and raises a number of questions. Is homocitrate synthase
in the nucleus enzymatically active? What is the significance of
nuclear localization for its catalytic activity? Are other enzymes of
the
-aminoadipate pathway located in the nucleus? Does homocitrate
synthase perform a function in the nucleus not directly related to
lysine biogenesis? Perhaps homocitrate synthase plays a role in nuclear
structure and/or function. The ILV5 gene product has been
shown to be required for two distinct functions in mitochondria:
branched chain amino acid synthesis and stabilization of mtDNA
inheritance (23). Homocitrate synthase is an example of an enzyme in an
unexpected location in the cell. The association of glycolytic enzymes
with the cytoskeleton was also unexpected, but a significant
consideration in understanding enzyme function (9).
Evelyne Dubois graciously communicated unpublished results regarding LYS20. Linda Green and Scherwin Henry of the ICBR Hybridoma laboratory provided assistance with the production of hybridoma cell lines and monoclonal antibodies.